Berliner Boersenzeitung - US greenlights pig kidney transplant trials

EUR -
AED 4.212777
AFN 72.835586
ALL 94.512843
AMD 422.248264
ANG 2.053494
AOA 1052.895931
ARS 1680.790338
AUD 1.635257
AWG 2.067368
AZN 1.95436
BAM 1.956354
BBD 2.309354
BDT 140.73988
BGN 1.939347
BHD 0.432422
BIF 3423.630825
BMD 1.146945
BND 1.480319
BOB 7.92328
BRL 5.90941
BSD 1.146625
BTN 108.087801
BWP 15.582008
BYN 3.185903
BYR 22480.122
BZD 2.305963
CAD 1.623185
CDF 2615.035015
CHF 0.925648
CLF 0.026299
CLP 1035.072439
CNY 7.764364
CNH 7.780559
COP 3960.034063
CRC 520.14739
CUC 1.146945
CUP 30.394043
CVE 110.569964
CZK 24.190336
DJF 203.835517
DKK 7.474072
DOP 66.986043
DZD 152.939427
EGP 57.331754
ERN 17.204175
ETB 181.647461
FJD 2.564
FKP 0.867567
GBP 0.866531
GEL 3.039852
GGP 0.867567
GHS 12.874504
GIP 0.867567
GMD 84.304874
GNF 10064.442782
GTQ 8.746478
GYD 239.84901
HKD 8.988436
HNL 30.606273
HRK 7.533254
HTG 149.77244
HUF 351.906109
IDR 20445.785654
ILS 3.394682
IMP 0.867567
INR 108.1919
IQD 1502.49795
IRR 1577049.375404
ISK 143.976448
JEP 0.867567
JMD 181.171337
JOD 0.813229
JPY 185.008009
KES 148.419043
KGS 100.300781
KHR 4599.249852
KMF 492.617229
KPW 1032.250901
KRW 1752.130969
KWD 0.353179
KYD 0.955446
KZT 559.543917
LAK 25295.872375
LBP 102708.92515
LKR 382.668433
LRD 208.916469
LSL 18.815678
LTL 3.386631
LVL 0.693776
LYD 7.311819
MAD 10.580612
MDL 20.248208
MGA 4817.169398
MKD 61.628611
MMK 2408.272435
MNT 4107.54883
MOP 9.256923
MRU 45.947051
MUR 54.881752
MVR 17.720734
MWK 1992.243861
MXN 19.872547
MYR 4.745948
MZN 73.301688
NAD 18.814173
NGN 1560.350288
NIO 41.990088
NOK 11.102662
NPR 172.945006
NZD 1.997675
OMR 0.441554
PAB 1.14663
PEN 3.881306
PGK 5.032508
PHP 69.638491
PKR 319.223511
PLN 4.259467
PYG 7041.056554
QAR 4.175458
RON 5.239364
RSD 117.183799
RUB 83.845404
RWF 1679.12748
SAR 4.299026
SBD 9.24601
SCR 15.693948
SDG 688.744688
SEK 10.98638
SGD 1.482316
SHP 0.85631
SLE 28.387314
SLL 24050.86738
SOS 655.483268
SRD 42.898615
STD 23739.445827
STN 24.544623
SVC 10.032843
SYP 126.774237
SZL 18.814083
THB 37.723444
TJS 10.63456
TMT 4.014308
TND 3.339618
TOP 2.761569
TRY 53.262066
TTD 7.775237
TWD 36.375404
TZS 3017.595134
UAH 51.508996
UGX 4173.182519
USD 1.146945
UYU 45.84299
UZS 13769.075108
VES 695.774297
VND 30176.12295
VUV 136.226685
WST 3.156058
XAF 656.142926
XAG 0.017685
XAU 0.000276
XCD 3.099677
XCG 2.066386
XDR 0.807102
XOF 648.024305
XPF 119.331742
YER 273.665193
ZAR 18.876464
ZMK 10323.885445
ZMW 20.552914
ZWL 369.315822
  • CMSD

    0.0000

    22.29

    0%

  • NGG

    -1.2400

    79.44

    -1.56%

  • CMSC

    0.0500

    22.37

    +0.22%

  • BCC

    3.8500

    74.66

    +5.16%

  • RELX

    -0.8300

    31.18

    -2.66%

  • RBGPF

    -0.5300

    60.61

    -0.87%

  • RIO

    -2.5900

    100.08

    -2.59%

  • GSK

    -1.4800

    50.67

    -2.92%

  • BCE

    0.0000

    23.28

    0%

  • JRI

    0.0500

    12.67

    +0.39%

  • VOD

    -0.2300

    14.3

    -1.61%

  • BTI

    -0.5800

    58.91

    -0.98%

  • RYCEF

    -0.0300

    18.4

    -0.16%

  • AZN

    -2.9600

    174.93

    -1.69%

  • BP

    -1.0400

    39.1

    -2.66%

US greenlights pig kidney transplant trials
US greenlights pig kidney transplant trials / Photo: Andrew Caballero-Reynolds - AFP/File

US greenlights pig kidney transplant trials

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.

Text size:

United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.

Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.

United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.

The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.

The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.

Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.

"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.

Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.

Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.

Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.

United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.

Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.

She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.

(A.Lehmann--BBZ)